News

press

Nov 4, 2021

Press Release

Shasqi to Present Data Updates at Upcoming SITC and CTOS Meetings

conference

Oct 20, 2021

2021 - CTOS - Clinical Poster

First-in-human trial of SQ3370 in relapsed or refractory soft tissue sarcoma and other solid tumors: proof-of-concept for the click chemistry- based CAPAC platform

conference

Oct 18, 2021

2021 - CTOS - Preclinical Poster

Click Activated Protodrugs Against Cancer (CAPAC) Platform Enhances Antitumor Efficacy, Safety and Pharmacokinetics of Cancer Therapeutics

conference

Oct 17, 2021

2021 - SITC - Preclinical Poster

Combination of click chemistry-based SQ3370 with immunotherapies enhances antitumor effect in murine tumors with minimized systemic toxicity

conference

Oct 13, 2021

2021 - SITC - Clinical Poster

Pharmacokinetic and immunologic data from a Phase I study of the click chemistry-based therapy SQ3370 in advanced solid tumors and soft-tissue sarcoma provides proof-of-concept for the CAPAC platform

press

Sep 16, 2021

Press Release

Shasqi Presents Initial Data Validating Approach of Click Chemistry Activated Oncology Therapeutics at ESMO Congress 2021

conference

Aug 29, 2021

2021 - ESMO - Preclinical Poster

Click Activated Protodrugs Against Cancer (CAPAC) Platform Enhances the Safety, Pharmacokinetics, and Antitumor Efficacy of Cancer Therapies in vivo

conference

Aug 29, 2021

2021 - ESMO - Clinical Poster

Early pharmacokinetic data from a Phase I study of SQ3370 (NCT04106492) in patients with advanced solid tumors provides proof-of-concept for the click chemistry-based CAPAC platform

press

Apr 27, 2021

Press Release

Shasqi Awarded Prestigious Direct-to-Phase-2 Small Business Innovation Research Grant by National Cancer Institute

press

Apr 10, 2021

Press Release

Shasqi to Present Data on Novel Click Chemistry Platform at the American Association for Cancer Research (AACR) Annual Meeting

conference

Mar 25, 2021

2021 - AACR - Preclinical Poster

The CAPAC Platform Maximizes Therapeutic Benefit and Reduces Systemic Cytotoxic Exposure in Small and Large Animals

conference

Mar 25, 2021

2021 - AACR - Clinical Poster

First-in-human Phase I Study of SQ3370, a Click Activated Protodrug Therapy, in Patients with Advanced Solid Tumors